Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-14

Clinical Trial Update: Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating autologous adipose-derived regenerative cells for male stress urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous adipose-derived regenerative cells (adipose-derived regenerative cells)

Snippet

Sponsor: Nagoya University | Conditions: Urinary Incontinence , Stress | Phase 3 | Status: COMPLETED